
0:46
Excerpt from a YouTube talk describing an internal 13-week semaglutide run-in among employees that produced ~14% average body-weight loss (predominantly women). Participants were taken off semaglutide, given metformin (reported to raise GLP‑1), and allowed intermittent semaglutide self-dosing from an office supply as needed; at one year participants reportedly maintained the weight loss.
Questions this video answers
13 weeks
About 14% of body weight
Metformin
Everyone kept their weight off at one year
Mostly women (very few men)










